ARIKAYCE

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, Finland, Ireland, Japan, Lithuania, Netherlands, Poland, UK.

Active ingredients

The drug ARIKAYCE contains one active pharmaceutical ingredient (API):

1	Amikacin UNII 84319SGC3C - AMIKACIN
	Amikacin is an antibiotic used for a number of bacterial infections. Amikacin works by blocking the function of the bacteria’s 30S ribosomal subunit, making it unable to produce proteins.
	Read more about Amikacin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ARIKAYCE Inhalation suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01GB06	Amikacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1831429
FI	Lääkealan turvallisuus- ja kehittämiskeskus	191886
GB	Medicines & Healthcare Products Regulatory Agency	395830
JP	医薬品医療機器総合機構	6169700G1025
LT	Valstybinė vaistų kontrolės tarnyba	1091321
NL	Z-Index G-Standaard, PRK	206237
PL	Rejestru Produktów Leczniczych	100446218
US	FDA, National Drug Code	71558-590